CRIS Current Research Information System

ROMANIELLO, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.671
NA - Nord America 1.714
EU - Europa 1.661
SA - Sud America 194
AF - Africa 58
OC - Oceania 3
Totale 6.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.678
IT - Italia 897
VN - Vietnam 746
SG - Singapore 744
CN - Cina 646
BR - Brasile 157
HK - Hong Kong 156
DE - Germania 154
FR - Francia 98
KR - Corea 92
IE - Irlanda 89
GB - Regno Unito 83
NL - Olanda 68
JP - Giappone 59
SE - Svezia 59
FI - Finlandia 54
BD - Bangladesh 52
IN - India 43
RU - Federazione Russa 41
AT - Austria 32
AR - Argentina 21
CI - Costa d'Avorio 21
CA - Canada 20
ID - Indonesia 20
ES - Italia 19
TH - Thailandia 15
PL - Polonia 13
BG - Bulgaria 12
CH - Svizzera 12
PH - Filippine 12
TW - Taiwan 12
IQ - Iraq 11
MX - Messico 11
JO - Giordania 10
SC - Seychelles 10
PK - Pakistan 9
DK - Danimarca 8
TG - Togo 8
ZA - Sudafrica 8
EC - Ecuador 7
SA - Arabia Saudita 7
TR - Turchia 7
IR - Iran 6
BE - Belgio 5
MY - Malesia 5
MA - Marocco 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
PY - Paraguay 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 6.301
Salva come PNG Salva come JPEG
Città #
Singapore 487
Bologna 415
Ashburn 210
Hefei 197
Ho Chi Minh City 195
Hanoi 188
San Jose 180
Hong Kong 146
Santa Clara 132
Chandler 112
Dublin 86
Seoul 83
Boardman 81
Beijing 77
Princeton 70
Lauterbourg 66
Dallas 55
Council Bluffs 53
Milan 48
Los Angeles 47
Tokyo 44
Berlin 37
Helsinki 36
Southend 36
New York 35
Modena 34
São Paulo 34
Da Nang 32
Fairfield 32
Munich 28
Rome 26
Buffalo 25
Vienna 25
Amsterdam 22
Frankfurt am Main 22
London 22
Medford 22
Abidjan 21
Guangzhou 20
Seattle 20
Haiphong 19
Nuremberg 18
Bengaluru 17
Redondo Beach 17
Naples 14
Shanghai 14
Brescia 13
Florence 13
Jakarta 13
The Dalles 13
Ninh Bình 12
Sofia 12
Lappeenranta 11
Orem 11
Amman 10
Can Tho 10
Chicago 10
Houston 10
Hải Dương 10
Phoenix 10
Vũng Tàu 10
Woodbridge 10
Bern 9
Bremen 9
Brooklyn 9
Olalla 9
Düsseldorf 8
Jinan 8
Lomé 8
Marcon 8
Reggio Emilia 8
Rimini 8
San Diego 8
Warsaw 8
Boydton 7
Bắc Giang 7
Cambridge 7
Falkenstein 7
Forlì 7
Redmond 7
Stanford 7
Thái Nguyên 7
Wilmington 7
Xi'an 7
Bangkok 6
Montreal 6
Toronto 6
Turin 6
Turku 6
Alicante 5
Atlanta 5
Chengdu 5
Ferrara 5
Ha Long 5
Long An 5
Madrid 5
Palermo 5
Quận Ba 5
Quận Bình Thạnh 5
Taipei 5
Totale 4.033
Salva come PNG Salva come JPEG
Nome #
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 311
The natural sesquiterpene β- caryophyllene acts as an enviromental decontaminant through the interference with the STAT3 signalling pathway 253
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 236
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 224
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 220
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 216
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 210
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 203
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 203
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 201
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 199
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 196
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 188
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 175
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 138
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 136
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 135
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 123
Senescence-associated reprogramming impairs response to EGFR neutralization 116
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells 105
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 96
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 95
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 94
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 92
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 90
First-line therapy based on kinase inhibitors and antibodies prevents resistance in egfr-mutated lung cancer. 84
Senescence-associated reprogramming impairs response to EGFR neutralization 83
β-Hexachlorocyclohexane Drives Carcinogenesis in the Human Normal Bronchial Epithelium Cell Line BEAS-2B 83
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 81
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 77
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung Cancer 77
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor 76
Synergy Between Kinase Inhibitors And Antibodies Enables Upfront Prevention Of Recurring Secondary Resistance In Egfr-Mutated Lung Cancer 75
Comparative analysis of the interaction between different flavonoids and pdia3 74
JAK2-Regulation Of HER2 “Addiction” In HER2-Positive Breast Cancer Cell Lines 74
Cancer Immunotherapy: The Dawn of Antibody Cocktails 73
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 72
Biochemical characterization of the ERp57-STAT3 complex 71
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 65
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 64
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 63
STAT3 post-translational modifications drive cellular signaling pathways in prostate cancer cells 62
Dangerous liaison: organochlorine substances, energy metabolism and cancer 60
STAT3--ERp57 Interplay in human prostate cancer 59
Analysis of stat3 post-translational modifications (ptms) in human prostate cancer with different gleason scores 59
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways 57
Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid 57
Circadian dependent motility: the role for the perinuclear actin cap 57
Functional Studies Of Stat3 And Its Interactors In Breast Cancer 56
Interaction between flavonoids and PDIA3 56
Protease, an Advance Therapeutic Target in Cancer 53
EGFR/STAT3/ERp57 Interplay in human prostate cancer progression 53
PARP-1 as coactivator of STAT3 in M14 melanoma cell line 50
STAT3/ERP57/TPX2 axis and process of “androgen escape” in prostate cancer 49
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 47
null 46
STAT3's role in microglial cells 46
STAT3-EGFR PATHWAY IN NEUROENDOCRINE PROSTATE CANCER: A CASE REPORT 45
The ERBB Family of Receptor Tyrosine Kinases: Key Players in Cancer 42
null 39
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 14
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 12
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 8
null 4
Totale 6.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022294 0 3 0 0 3 3 1 35 42 15 118 74
2022/2023624 53 58 24 55 70 50 16 59 124 10 54 51
2023/2024366 44 42 36 30 22 63 14 27 14 28 16 30
2024/20251.514 33 181 131 94 207 93 171 72 72 113 114 233
2025/20263.580 411 362 299 235 282 217 323 191 661 241 214 144
Totale 6.478